Stocks
AZN’s Imfinzi Combo Wins Late-Stage Liver Cancer Trial
AstraZeneca (AZN) announced a successful late-stage trial for its Imfinzi combination regimen in a subset of liver cancer patients, bolstering the company's...
AstraZeneca (AZN) announced a successful late-stage trial for its Imfinzi combination regimen in a subset of liver cancer patients, bolstering the company's...